Persistent PORT-A-CATH®-related fistula and fibrosis in a breast cancer patient successfully treated with local ozone application.

Research activity related to this work was supported, in part, by the I3SNS Program from the Instituto de Salud Carlos III (INT07/030 for BC and INT 07/172 for NS), Madrid, Spain. The ozone therapy device, Ozonosan Alpha-plus®, was provided by Dr. Hansler GmbH (Iffezheim, Germany). Editorial assistance was provided by Dr. Peter R. Turner of t-SciMed (Reus, Spain).